Xiaoling Wu
Shanghai Medical College of Fudan University(CN)Beijing University of Chinese Medicine(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Fudan University(CN)Fourth People's Hospital of Sichuan Province(CN)Zhongshan Hospital(CN)Henan Provincial People's Hospital(CN)Sanya Central Hospital(CN)Ministry of Education(ET)First Affiliated Hospital of Jinan University(CN)
Publications by Year
Research Areas
Cancer-related molecular mechanisms research, RNA modifications and cancer, Liver Disease Diagnosis and Treatment, Cancer-related Molecular Pathways, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → An integrated national mortality surveillance system for death registration and mortality surveillance, China(2015)394 cited
- → Prevalence and associated factors of depression and anxiety among nurses during the outbreak of COVID-19 in China: A cross-sectional study(2020)204 cited
- → Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack(2022)133 cited
- → MicroRNA-34A inhibits the growth, invasion and metastasis of gastric cancer by targeting PDGFR and MET expression(2014)103 cited
- → Glucagon Like Peptide-1 (GLP-1) Modulates OVA-Induced Airway Inflammation and Mucus Secretion Involving a Protein Kinase A (PKA)-Dependent Nuclear Factor-κB (NF-κB) Signaling Pathway in Mice(2015)102 cited
- → Daxx Cooperates with the Axin/HIPK2/p53 Complex to Induce Cell Death(2007)